Nonhormonal pharmacotherapies that are effective in treating postmenopausal vasomotor symptoms include serotonin–norepinephrine reuptake inhibitors such as desvenlafaxine and venlafaxine. In a recent literature review, these pharmacological treatments were found to be safe, efficacious, and well-tolerated. Approximately 60–80% of menopausal women experience vasomotor symptoms during the initial 7 years of the onset of menopause, which have...